← Eichor
Condition: Von Willebrand Disease Type 3 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Von Willebrand Disease Type 3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Severe Von Willebrand Disease (sVWD) Patient Registry
Phase N/A · 1 location(s) · VWD Connect Foundation · NCT05437536A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Phase N/A · 17 location(s) · Hemab ApS · NCT06610201Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Phase 3 · 14 location(s) · Vega Therapeutics, Inc · NCT07115004A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Phase 3 · 21 location(s) · Takeda · NCT05582993A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
Phase 3 · 28 location(s) · Hoffmann-La Roche · NCT06998524A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · 25 location(s) · Hemab ApS · NCT06754852Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Phase 1 · 12 location(s) · Bleeding and Clotting Disorders Institute Peoria, Illinois · NCT05500807
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.